Table 1.
Gene | Sense (5′–3′) | Antisense (5′–3′) | Expected product size (bp) | GenBank accession |
---|---|---|---|---|
hBest1 5′ | 304-GTATTGCGACAGCTACATCCAG-327 | 794-ATCCAGTCGTAGGCATACAGGT-771 | 488 | NM 004183 |
hBest1 mid | 771-ACCTGTATGCCTACGACTGGAT-794 | 1233-CTGGAACTCCATCTCCTCTTTG-1210 | 460 | NM 004183 |
hBest1 3′ | 1105-GGACATGTACTGGAATAAGCCC-1128 | 1514-GTGTCTGGGGCACTGTAGTC-1493 | 407 | NM 004183 |
hBest2 | 443-AGTTTGAAAACCTGAACTCATCCTA-469 | 865-AGAAAGTTGGTCTCAAAGTCATCAT-839 | 420 | NM 017682 |
hBest3 | 833-ACAAGTGACAGCTCCATGTTCTTAC-859 | 1350-TTTTAGAAAGGTATCACCAGGGTCT-1324 | 515 | NM 032735 |
hBest4 | 957-TTTGAGACAAATCAGCTCATAGACC-983 | 1568-TCTTCTCTTTCAAGTTCTGTCCCTA-1544 | 609 | NM 153274 |
β-Actin | 260-GCATCCTCACCCTGAAGTAC-281 | 717-TTCTCCTTAATGTCACGCAC-697 | 455 | NM 001101 |
GAPDH | 627-ACCACAGTCCATGCCATCAC-648 | 1080-TCCACCACCCTGTTGCTGTA-1059 | 451 | NM 002046 |
PCR primers for hBest1, 2, 3, 4, β-actin and GAPDH that have been used in this study. Primers were designed using the OligoPerfect™ primer design programme by Invitrogen.